Halozyme Therapeutics HALO
NASDAQ HALO
$101.94 +0.26 (+0.26%)
As of: Nov 12, 2026 · 10:08 AM EST

Halozyme Therapeutics (HALO) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Halozyme Therapeutics (HALO) recorded Return on Capital Employed [ROCE] of 26.19% in Q2 2026, down 8.10 percentage points from 34.29% a year earlier but up 3.29 percentage points from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Halozyme Therapeutics reported Return on Capital Employed [ROCE] of 22.15%, down 9.20 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -73.06 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at 31.35% in FY2024 (+11.19 pp), 20.15% in FY2023 (+0.22 pp), 19.93% in FY2022 (-18.12 pp) and 38.05% in FY2021 (-57.16 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from 14.56% in Q3 2022 to 56.71% in Q3 2025 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for three consecutive quarters, with an average year-over-year change of +5.47 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 32.06 percentage points in Q3 2025, against a drop of 83.62 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at 22.90% (Q1 2026), 21.36% (Q4 2025) and 56.71% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Halozyme Therapeutics 11.73 Bn 9.97 Bn 410.50 Mn 26.45%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 26.45%
Jun 30, 2026 26.19%
Mar 31, 2026 22.90%
Dec 31, 2025 21.36%
Sep 30, 2025 56.71%
Jun 30, 2025 34.29%
Mar 31, 2025 30.18%
Dec 31, 2024 28.26%
Sep 30, 2024 24.65%
Jun 30, 2024 22.69%
Mar 31, 2024 22.91%
Dec 31, 2023 19.85%
Sep 30, 2023 17.91%
Jun 30, 2023 18.68%
Mar 31, 2023 14.64%
Dec 31, 2022 15.53%
Sep 30, 2022 14.56%
Jun 30, 2022 19.01%
Mar 31, 2022 29.45%
Dec 31, 2021 26.84%
API Access

Halozyme Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=HALO&period=max&api_key=YOUR_API_KEY